Towards detection and diagnosis of Ebola virus disease at point-of-care

Baden, 2014, Ebola - an ongoing crisis, N. Engl. J. Med., 371, 1458, 10.1056/NEJMe1411378 Bah, 2014, Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea, 372, 40 Baize, 2002, Inflammatory responses in Ebola virus†infected patients, Clin. Exp. Immunol., 128, 163, 10.1046/j.1365-2249.2002.01800.x Baize, 2014, Emergence of Zaire Ebola Virus Disease in Guinea, N. Engl. J. Med., 371, 1418, 10.1056/NEJMoa1404505 Bar, 2006, Detection of cell-cell fusion mediated by Ebola virus glycoproteins, Journal of virology, 80, 2815, 10.1128/JVI.80.6.2815-2822.2006 Beeching, 2014, Ebola virus disease, Br. Med. J., 349, g7348, 10.1136/bmj.g7348 Bornholdt, 2013, Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle, Cell, 154, 763, 10.1016/j.cell.2013.07.015 Breman, 2014, Ebola Then and Now, N. Engl. J. Med., 371, 1663, 10.1056/NEJMp1410540 Briand, 2014, The International Ebola Emergency, N. Engl. J. Med., 371, 1180, 10.1056/NEJMp1409858 Burd, 2015, Ebola Virus: a Clear and Present Danger, J. Clin. Microbiol., 53, 4, 10.1128/JCM.03115-14 Butler, 2014, Ebola experts seek to expand testing, Nature, 516 Carette, 2011, Ebola virus entry requires the cholesterol transporter Niemann-Pick C1, Nature, 477, 340, 10.1038/nature10348 Carod-Artal, 2015, Illness due the Ebola virus: epidemiology and clinical manifestations within the context of an international public health emergency, Rev. Neurol., 60, 267 Chan, 2014, Ebola Virus Disease in West Africa — No Early End to the Outbreak, N. Engl. J. Med., 371, 1183, 10.1056/NEJMp1409859 Chandran, 2005, Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection, Science, 308, 1643, 10.1126/science.1110656 Chertow, 2014, Ebola Virus Disease in West Africa — Clinical Manifestations and Management, N. Engl. J. Med., 371, 2054, 10.1056/NEJMp1413084 Choi, 2013, Emerging targets and novel approaches to Ebola virus prophylaxis and treatment, BioDrugs, 27, 565, 10.1007/s40259-013-0046-1 Choi, 2014, A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal Ebola infection, Mol. Pharmaceut. Cowling, 2015, Ebola: worldwide dissemination risk and response priorities, The Lancet, 385, 7, 10.1016/S0140-6736(14)61895-X Cruz, 2014, A low-cost miniaturized potentiostat for point-of-care diagnosis, Biosens. Bioelectron., 62, 249, 10.1016/j.bios.2014.06.053 Daaboul, 2014, Digital sensing and sizing of vesicular stomatitis virus pseudotypes in complex media: a model for ebola and Marburg detection, ACS nano, 8, 6047, 10.1021/nn501312q De Clercq, 2015, Ebola virus (EBOV) infection: Therapeutic strategies, Biochem. Pharmacol., 93, 1, 10.1016/j.bcp.2014.11.008 Dhillon, 2014, Controlling Ebola: next steps, The Lancet, 384, 1409, 10.1016/S0140-6736(14)61696-2 Drazen, 2014, Ebola in West Africa at One Year - From Ignorance to Fear to Roadblocks, N. Engl. J. Med., 0 Drosten, 2002, Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR, J. Clin. Microbiol., 40, 2323, 10.1128/JCM.40.7.2323-2330.2002 Farrar, 2014, The Ebola emergency - immediate action, ongoing strategy, N. Engl. J. Med., 371, 1545, 10.1056/NEJMe1411471 Fauci, 2014, Ebola-underscoring the global disparities in health care resources, N. Engl. J. Med., 371, 1084, 10.1056/NEJMp1409494 Feldmann, 2014, Ebola-A growing threat?, N. Engl. J. Med., 371, 1375, 10.1056/NEJMp1405314 Feldmann, 2014, Ebola -A Growing Threat?, N. Engl. J. Med., 371, 1375, 10.1056/NEJMp1405314 Feldmann, 2011, Ebola hemorrhagic fever, The Lancet, 377, 849, 10.1016/S0140-6736(10)60667-8 Feldmann, 2004, Ebola virus ecology: a continuing mystery, Trends Microbiol., 12, 433, 10.1016/j.tim.2004.08.009 Formenty, 2006, Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo, Clin. Infect. Dis., 42, 1521, 10.1086/503836 Frieden, 2014, Ebola 2014 - New Challenges, New Global Response and Responsibility, N. Engl. J. Med., 371, 1177, 10.1056/NEJMp1409903 Gire, 2014, Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak, Science, 345, 1369, 10.1126/science.1259657 Goodman, 2014, Studying Secret Serums- Toward Safe, Effective Ebola Treatments, N. Engl. J. Med., 371, 1086, 10.1056/NEJMp1409817 Grolla, 2005, Laboratory diagnosis of Ebola and Marburg hemorrhagic fever, Bull. Soc. Pathol. Exotique, 98, 205 Hatfill, 2014, Ebola Virus Disease, J. Am. Phys. Surgeons, 19, 4 Hill, 2014, Laboratory test support for Ebola patients within a high-containment facility, Lab Med., 45, e109, 10.1309/LMTMW3VVN20HIFS Huang, 2012, Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays, Virol. Sin., 27, 273, 10.1007/s12250-012-3252-y Ikegami, 2002, Development of an immunofluorescence method for the detection of antibodies to ebola virus subtype reston by the use of recombinant nucleoprotein†expressing HeLa Cells, Microbiol. Immunol., 46, 633, 10.1111/j.1348-0421.2002.tb02745.x Iwen, 2014, An integrated approach to laboratory testing for patients with ebola virus disease, Lab Med., 45, e146, 10.1309/LMTULFM62W3RKMYI Johnson, 2014, Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells, 102 Kanapathipillai, 2014, Ebola Virus Disease: Current Knowledge, N. Engl. J. Med., 371, e18, 10.1056/NEJMp1410741 Kanapathipillai, 2014, Ebola Vaccine- An Urgent International Priority, N. Engl. J. Med., 371, 2249, 10.1056/NEJMp1412166 Karwowska, 2015, Ebola virus disease, Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego, 38, 42 Kaushik, 2014, Miniaturized Sensing Devices for Biomarker Detection, J. Biosens. Bioelectron., 5, 1000e1132 Kaushik, 2014, Recent advances in cortisol sensing technologies for point-of-care application, Biosens. Bioelectron., 53, 499, 10.1016/j.bios.2013.09.060 Kawaoka, 2005, How Ebola Virus Infects Cells, N. Engl. J. Med., 352, 2645, 10.1056/NEJMcibr051754 Kurosaki, 2007, Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification, J. Virol. Methods, 141, 78, 10.1016/j.jviromet.2006.11.031 Lamontagne, 2014, Doing Today Work Superbly Well — Treating Ebola with Current Tools, N. Engl. J. Med., 371, 1565, 10.1056/NEJMp1411310 Li, 2014, Development of therapeutics for treatment of Ebola virus infection, Microbes and Infection, 10.1007/978-3-662-43883-1 Li, 2005, Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes, Nature biotechnology, 23, 885, 10.1038/nbt1106 Lucht, 2007, Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection, J. Infect. Dis., 196, S184, 10.1086/520593 Lucht, 2003, Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus, J. Virol. Methods, 111, 21, 10.1016/S0166-0934(03)00131-9 Lyon, 2014, Clinical care of two patients with Ebola virus disease in the United States, N. Engl. J. Med., 371, 2402, 10.1056/NEJMoa1409838 MacIntyre, 2014, Respiratory protection for healthcare workers treating Ebola virus disease (EVD): Are facemasks sufficient to meet occupational health and safety obligations?, 51, 1421 Maganga, 2014, Ebola Virus Disease in the Democratic Republic of Congo, N. Engl. J. Med., 371, 2083, 10.1056/NEJMoa1411099 Martin, 2015, Laboratory diagnosis of Ebola virus disease, Intens. Care Med., 1 Martines, 2015, Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses, J. Pathol., 235, 153, 10.1002/path.4456 Marzi, 2014, Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates, Proc. Natl. Acad. Sci., 110, 1893, 10.1073/pnas.1209591110 Miller, 2012, Ebola virus entry requires the host†programmed recognition of an intracellular receptor, EMBO J., 31, 1947, 10.1038/emboj.2012.53 Mitman, 2014, Ebola in a Stew of Fear, N. Engl. J. Med., 371, 1763, 10.1056/NEJMp1411244 Mohan, 2012, Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus, PLoS Pathogens, 8, e1003065, 10.1371/journal.ppat.1003065 Nakayama, 2010, Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies, Clin. Vaccine Immunol., 17, 1723, 10.1128/CVI.00170-10 Niikura, 2001, Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein, J. Clin. Microbiol., 39, 3267, 10.1128/JCM.39.9.3267-3271.2001 Nyakatura, 2015, Chemical and structural aspects of Ebola virus entry inhibitors, ACS Infect. Dis., 1, 42, 10.1021/id500025n Pardee, 2014, Paper-based synthetic gene networks, Cell, 159, 940, 10.1016/j.cell.2014.10.004 Peters, 1999, An introduction to Ebola: the virus and the disease, J. Infect. Dis., 179 Prehaud, 1998, Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections, J. Gen. Virol., 79, 2565, 10.1099/0022-1317-79-11-2565 Rivera, 2015, Pathophysiology of Ebola virus infection: Current challenges and future hopes, ACS Infect. Dis., 10.1021/id5000426 Rosenbaum, 2015, Communicating Uncertainty - Ebola, Public Health, and the Scientific Process, N. Engl. J. Med., 372, 7, 10.1056/NEJMp1413816 Rosenbaum, 2015, License to Serve - U.S. Trainees and the Ebola Epidemic, N. Engl. J. Med., 372, 504, 10.1056/NEJMp1415192 Rougeron, V., Feldmann, H., Grard, G., Becker, S., Leroy, E.M., 2015. Ebola and Marburg hemorrhagic fever. Sagripanti, 2011, Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces, Arch. Virol., 156, 489, 10.1007/s00705-010-0847-1 Saijo, 2006, Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins, Clin. Vaccine Immunol., 13, 444, 10.1128/CVI.13.4.444-451.2006 Saijo, 2001, Immunofluorescence method for detection of Ebola virus immunoglobulin G, using HeLa cells which express recombinant nucleoprotein, J. Clin. Microbiol., 39, 776, 10.1128/JCM.39.2.776-778.2001 Sanchez, 1999, Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates, J. Infect. Dis., 179, S164, 10.1086/514282 Stanley, 2014 Sullivan, 2003, Ebola virus pathogenesis: implications for vaccines and therapies, J. Virol., 77, 9733, 10.1128/JVI.77.18.9733-9737.2003 Sullivan, 2003, Accelerated vaccination for Ebola virus hemorrhagic fever in non-human primates, Nature, 424, 681, 10.1038/nature01876 Sullivan, 2000, Development of a preventive vaccine for Ebola virus infection in primates, Nature, 408, 605, 10.1038/35046108 Swamy, 2014, Current scenario of therapeutics for Ebola virus disease, Am. J. Infect. Dis., 10, 100, 10.3844/ajidsp.2014.100.104 Takada, 2012, Filovirus tropism: cellular molecules for viral entry, Front. Microbiol., 3, 34, 10.3389/fmicb.2012.00034 Tan, 2014, Ebola virus disease: Potential use of melatonin as a treatment, J. Pin. Res., 57, 381, 10.1111/jpi.12186 Trombley, 2010, Comprehensive Panel of Real-Time TaqManâ„¢ Polymerase Chain Reaction Assays for Detection and Absolute Quantification of Filoviruses, Arenaviruses, and New World Hantaviruses, Am. J. Trop. Med. Hyg., 82, 954, 10.4269/ajtmh.2010.09-0636 Uebelhoer, L.S., Albariño, Cs.G., McMullan, L.K., Chakrabarti, A.K., Vincent, J.P., Nichol, S.T., Towner, J.S., 2014. High-throughput luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. 86–94. Van Kinh Nguyen, 2015, Ebola virus infection modeling and identifiability problems, Front. Microbiol., 6 Vasudev, 2013, An LTCC-based microfluidic system for label-free, electrochemical detection of cortisol, Sens. Actuators B: Chem., 182, 139, 10.1016/j.snb.2013.02.096 Vogel, 2014, Testing new Ebola tests, Science, 345, 1549, 10.1126/science.345.6204.1549 Wang, 2014, A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody, 254 Xu, 1998, Immunization for Ebola virus infection, Nat. Med., 4, 37, 10.1038/nm0198-037 Yang, 1998, Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins, Science, 279, 1034, 10.1126/science.279.5353.1034 Yanik, 2010, An optofluidic nanoplasmonic biosensor for direct detection of live viruses from biological media, Nano Lett., 10, 4962, 10.1021/nl103025u Yu, 2006, Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor, J. Virol. Methods, 137, 219, 10.1016/j.jviromet.2006.06.014